Frost & Sullivan Ranks POMDOCTOR in China Internet Hospital Market
1 report, 1 independent
Updated Tue 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Frost & Sullivan ranked POMDOCTOR as the sixth-ranked online medical services platform for chronic diseases in China, based on the number of contracted doctors in 2022. The company reported revenue of $13.62 million and earnings per share of ($7.30) for the quarter ending September 29th. Separately, POMDOCTOR saw a significant increase in short interest during October, rising 1,013.1% from October 15th to October 30th.
From dailypolitical.com
Why it matters
The ranking positions POMDOCTOR within China’s Internet hospital market. The company's stock traded up $0.05 during midday trading, while approximately 10.8% of its shares were short sold as of October 30th.
From dailypolitical.com
Who's involved
- Frost & SullivanAmerican business consulting firm that issued the market ranking